Lyell Immunopharma Inc (LYEL)
2.36
-0.04
(-1.67%)
USD |
NASDAQ |
May 03, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Price to Book Value: 0.9156 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.9156 |
| May 02, 2024 | 0.9311 |
| May 01, 2024 | 0.904 |
| April 30, 2024 | 0.8419 |
| April 29, 2024 | 0.8729 |
| April 26, 2024 | 0.8419 |
| April 25, 2024 | 0.8535 |
| April 24, 2024 | 0.8923 |
| April 23, 2024 | 0.9466 |
| April 22, 2024 | 0.935 |
| April 19, 2024 | 0.8652 |
| April 18, 2024 | 0.904 |
| April 17, 2024 | 0.9233 |
| April 16, 2024 | 0.935 |
| April 15, 2024 | 0.9311 |
| April 12, 2024 | 1.168 |
| April 11, 2024 | 1.032 |
| April 10, 2024 | 0.9505 |
| April 09, 2024 | 0.9777 |
| April 08, 2024 | 0.8496 |
| April 05, 2024 | 0.8108 |
| April 04, 2024 | 0.8108 |
| April 03, 2024 | 0.7992 |
| April 02, 2024 | 0.807 |
| April 01, 2024 | 0.8458 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.8652 |
| March 27, 2024 | 0.7914 |
| March 26, 2024 | 0.7526 |
| March 25, 2024 | 0.7449 |
| March 22, 2024 | 0.7449 |
| March 21, 2024 | 0.7914 |
| March 20, 2024 | 0.7895 |
| March 19, 2024 | 0.772 |
| March 18, 2024 | 0.807 |
| March 15, 2024 | 0.838 |
| March 14, 2024 | 0.8574 |
| March 13, 2024 | 0.9117 |
| March 12, 2024 | 0.8458 |
| March 11, 2024 | 0.904 |
| March 08, 2024 | 0.9738 |
| March 07, 2024 | 0.9777 |
| March 06, 2024 | 1.024 |
| March 05, 2024 | 0.9738 |
| March 04, 2024 | 1.011 |
| March 01, 2024 | 1.191 |
| February 29, 2024 | 1.133 |
| February 28, 2024 | 1.102 |
| February 27, 2024 | 1.106 |
| February 26, 2024 | 1.016 |
| February 23, 2024 | 0.9272 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.494
Minimum
Sep 20 2023
4.205
Maximum
Sep 10 2021
1.504
Average
1.159
Median
Price to Book Value Benchmarks
| GlycoMimetics Inc | 3.070 |
| Candel Therapeutics Inc | 20.77 |
| Eliem Therapeutics Inc | 2.616 |
| Entrada Therapeutics Inc | 1.824 |
| NovaBay Pharmaceuticals Inc | 2.094 |
Price to Book Value Related Metrics
| PS Ratio | 4556.23 |
| PEG Ratio | -0.0988 |
| Price | 2.36 |
| Earnings Yield | -39.41% |
| Market Cap | 599.67M |
| PEGY Ratio | -0.0988 |